找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Rare Lymphomas; Martin Dreyling,Michael E. Williams Book 2014 Springer-Verlag Berlin Heidelberg 2014 Malignant Lymphoma.Molecular Pathogen

[复制链接]
查看: 23198|回复: 56
发表于 2025-3-21 17:09:29 | 显示全部楼层 |阅读模式
书目名称Rare Lymphomas
编辑Martin Dreyling,Michael E. Williams
视频video
概述Focuses on the rare lymphomas often not covered in other books.Provides a comprehensive overview of current treatment strategies.Emphasizes translation of molecular science into clinical care.Most cha
丛书名称Hematologic Malignancies
图书封面Titlebook: Rare Lymphomas;  Martin Dreyling,Michael E. Williams Book 2014 Springer-Verlag Berlin Heidelberg 2014 Malignant Lymphoma.Molecular Pathogen
描述After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity.
出版日期Book 2014
关键词Malignant Lymphoma; Molecular Pathogenesis; Targeted Approaches
版次1
doihttps://doi.org/10.1007/978-3-642-39590-1
isbn_softcover978-3-662-50772-8
isbn_ebook978-3-642-39590-1Series ISSN 2197-9766 Series E-ISSN 2197-9774
issn_series 2197-9766
copyrightSpringer-Verlag Berlin Heidelberg 2014
The information of publication is updating

书目名称Rare Lymphomas影响因子(影响力)




书目名称Rare Lymphomas影响因子(影响力)学科排名




书目名称Rare Lymphomas网络公开度




书目名称Rare Lymphomas网络公开度学科排名




书目名称Rare Lymphomas被引频次




书目名称Rare Lymphomas被引频次学科排名




书目名称Rare Lymphomas年度引用




书目名称Rare Lymphomas年度引用学科排名




书目名称Rare Lymphomas读者反馈




书目名称Rare Lymphomas读者反馈学科排名




单选投票, 共有 1 人参与投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:47:52 | 显示全部楼层
发表于 2025-3-22 04:00:51 | 显示全部楼层
Molecular Genetics of Rare Lymphomas behavior. Recent improvements in pathologic diagnosis as well as the application of novel molecular biological techniques in clinical routine have led to the distinction of various subtypes of malignant lymphoma that occur at rather low frequencies. These lymphoma subtypes are here referred to as “
发表于 2025-3-22 08:07:40 | 显示全部楼层
发表于 2025-3-22 11:01:41 | 显示全部楼层
发表于 2025-3-22 16:51:41 | 显示全部楼层
发表于 2025-3-22 19:22:57 | 显示全部楼层
发表于 2025-3-22 23:44:38 | 显示全部楼层
Cutaneous T-Cell Lymphomaoming T lymphocytes. Clinically, they appear in considerable variability as cutaneous lesions, but mostly without signs of further nodal or systemic involvement and in many instances they keep confined to the skin for a indefinite time. Historically, mycosis fungoides (MF) and Sézary syndrome (SS) h
发表于 2025-3-23 03:19:45 | 显示全部楼层
发表于 2025-3-23 06:13:27 | 显示全部楼层
Primary Mediastinal Large B-Cell Lymphomastitutes 6–10 % of all diffuse large B-cell lymphomas (DLBCL), occurring more often in young females. It is characterised by a diffuse proliferation of medium to large B cells associated with sclerosis and a degree of compartmentalisation. CD30 staining is observed in the vast majority of cases (~80
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-4 01:35
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表